ISB News

Brain Health & Research Institute Enters Scientific Partnership with ISB, Aims to Provide Patients with Hope, Proven Results

Brain health expert Dr. Mary Kay Ross on Tuesday announced the creation of the Brain Health & Research Institute (BHRI) in Seattle. The new institute is dedicated to the evaluation, prevention, and treatment of neurodegenerative diseases, including Alzheimer’s Disease and dementia.

Dr. Mary Kay Ross

Brain health expert Dr. Mary Kay Ross announced the new Brain Health & Research Institute, which opens its doors in Seattle in September 2019.

BHRI has entered into a scientific collaboration with ISB. Through that partnership, BHRI will blend the practical application of medical therapies and treatment protocols with the advanced scientific analysis now available through personalized medicine and computational biology.

“This is a unique opportunity to bring the most advanced concepts in personalized medicine, with scientific rigor, to crippling diseases such as Alzheimer’s Disease,” said ISB President Dr. Jim Heath.

BHRI will open its doors in September.

“Our work must remain on the leading edge of biology, but must also be put to use for the benefit of millions of people suffering the scourge of brain disease,” said Dr. Lee Hood, ISB co-founder and senior vice president and chief science officer of Providence St. Joseph Health. “With her years of successful functional medicine practice and her deep experience with the complex and layered nature of Alzheimer’s I couldn’t be any prouder of our scientific partnership with Dr. Ross and her team.”

All patient-related questions should be directed to Brain Health & Research Institute. Please contact them here

Recent Articles

  • Building a Better BMI

    ISB researchers have constructed biological body mass index (BMI) measures that offer a more accurate representation of metabolic health and are more varied, informative and actionable than the traditional, long-used BMI equation. The work was published in the journal Nature Medicine. 

  • How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells

    In a just-published paper in the journal Nature, a collaborative team of researchers from ISB, UCLA, PACT Pharma, and beyond analyzed T-cell responses in melanoma patients who were treated with different immune checkpoint inhibitors, and how those responses evolved over time.

  • Spotlight on ISB Education graphic

    2022-23 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2022-2023 academic year, we will highlight some of the top projects the team is working on.